Compare HVT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HVT | SLP |
|---|---|---|
| Founded | 1885 | 1996 |
| Country | United States | United States |
| Employees | 2392 | N/A |
| Industry | Other Specialty Stores | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.8M | 326.7M |
| IPO Year | N/A | 1996 |
| Metric | HVT | SLP |
|---|---|---|
| Price | $24.98 | $18.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 87.2K | ★ 481.3K |
| Earning Date | 05-05-2026 | 04-09-2026 |
| Dividend Yield | ★ 6.05% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | $8.83 | $3.80 |
| Revenue Next Year | $8.70 | $5.90 |
| P/E Ratio | ★ $22.08 | $69.77 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $19.53 | $11.09 |
| 52 Week High | $27.67 | $21.01 |
| Indicator | HVT | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 66.44 | 67.00 |
| Support Level | $20.16 | $17.74 |
| Resistance Level | $25.27 | $18.76 |
| Average True Range (ATR) | 0.72 | 0.39 |
| MACD | 0.14 | 0.07 |
| Stochastic Oscillator | 75.04 | 87.18 |
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.